SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies is a research paper published in Signal Transduction and Targeted Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 135 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | National Institutes of Health
Grant: R01AI157975
U.S. Department of Health & Human Services | National Institutes of Health
Grant: R01AI137472
U.S. Department of Health & Human Services | National Institutes of Health
Grant: R01AI139092
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 5R01AI137472-03
Rational design and evaluation of novel mRNA vaccines against MERS-CoV
National Institutes of Health
Grant: 7R01AI157975-02
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
National Institutes of Health
Grant: 5R01AI139092-04
Structure-based design of coronavirus subunit vaccines
U.S. Department of Health & Human Services | National Institutes of Health
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
Additional file 1 of Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
Additional file 2 of Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
Additional file 2 of Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients